Phycin strives to produce recombinant human growth factors in algae that outperform the competitions with minimal bio risks, high performance, and cost effectiveness. Phycin has developed proprietary technologies to produce recombinant human growth factors in green algae. The algae derived growth factors are animal free, endotoxin free, highly potent, and fairly inexpensive. Particularly, the engineered thermostable bFGF is the most robust in the market. Phycin is uniquely positioned to provide a full catalogue of the much sought after growth factors to serve the regenerative medicine industry by addressing the unmet needs.
MSCRF funded the development of the technology.